Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 22 August, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 532485 | NSE: BLIL

Balmer Lawrie Investment Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 21, 2025, 11:12 pm

Market Cap 2,029 Cr.
Current Price 91.4
High / Low 100/60.0
Stock P/E11.6
Book Value 62.0
Dividend Yield4.70 %
ROCE17.3 %
ROE13.2 %
Face Value 1.00
PEG Ratio0.70

Quick Insight

Balmer Lawrie Investment Ltd, a Non-Banking Financial Company, currently trades at a price of 84.6 with a market cap of 1,879 Cr. The company boasts a P/E ratio of 11.0, ROE of 13.2%, and ROCE of 17.3%, indicating solid profitability and efficient capital utilization. With an OPM of 16% and a healthy net profit of 267 Cr, Balmer Lawrie Investment Ltd shows stability and growth potential. The company's strong reserves of 1,354 Cr and a low borrowing of ₹106Cr reflect a solid financial position. Moreover, the healthy ICR of 14.04x suggests the company's ability to meet its debt obligations comfortably. Overall, Balmer Lawrie Investment Ltd appears to be a fundamentally sound investment option with room for further growth and value appreciation.

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Balmer Lawrie Investment Ltd

Competitors of Balmer Lawrie Investment Ltd

Stock Name Market Cap Current Price High / Low Stock P/E Book Value Dividend Yield ROCE ROE Face Value
Minolta Finance Ltd 15.4 Cr. 1.54 1.91/0.78103 1.070.00 %0.40 %0.09 % 1.00
Money Masters Leasing & Finance Ltd 16.8 Cr. 1.67 15.6/1.0626.2 1.570.00 %2.44 %4.84 % 1.00
Moneyboxx Finance Ltd 441 Cr. 135 311/130 79.80.00 %8.73 %0.58 % 10.0
Moongipa Capital Finance Ltd 16.4 Cr. 17.9 41.0/17.912.3 24.90.00 %15.0 %9.43 % 10.0
Morarka Finance Ltd 45.2 Cr. 101 191/90.035.1 2120.99 %2.46 %2.17 % 10.0
Industry Average26,393.25 Cr503.19101.91498.560.20%15.80%8.89%8.48

All Competitor Stocks of Balmer Lawrie Investment Ltd

Quarterly Result

MetricJun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
Sales 649553516610594587587579641642633611683
Expenses 587513464556528511511485574569547514598
Operating Profit 62405255677776946673869786
OPM % 10%7%10%9%11%13%13%16%10%11%14%16%13%
Other Income 24241535242827303129223325
Interest 5455655665967
Depreciation 14141414151414151414151614
Profit before tax 6846477070858310376828410789
Tax % 17%24%22%38%18%25%19%27%15%24%24%30%22%
Net Profit 56353744576468756563647569
EPS in Rs 1.601.021.101.271.661.831.942.141.861.821.882.172.01

Last Updated: August 19, 2025, 10:45 pm

Below is a detailed analysis of the quarterly data for Balmer Lawrie Investment Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

  • For Sales, as of Jun 2025, the value is 683.00 Cr.. The value appears strong and on an upward trend. It has increased from 611.00 Cr. (Mar 2025) to 683.00 Cr., marking an increase of 72.00 Cr..
  • For Expenses, as of Jun 2025, the value is 598.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 514.00 Cr. (Mar 2025) to 598.00 Cr., marking an increase of 84.00 Cr..
  • For Operating Profit, as of Jun 2025, the value is 86.00 Cr.. The value appears to be declining and may need further review. It has decreased from 97.00 Cr. (Mar 2025) to 86.00 Cr., marking a decrease of 11.00 Cr..
  • For OPM %, as of Jun 2025, the value is 13.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Mar 2025) to 13.00%, marking a decrease of 3.00%.
  • For Other Income, as of Jun 2025, the value is 25.00 Cr.. The value appears to be declining and may need further review. It has decreased from 33.00 Cr. (Mar 2025) to 25.00 Cr., marking a decrease of 8.00 Cr..
  • For Interest, as of Jun 2025, the value is 7.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 1.00 Cr..
  • For Depreciation, as of Jun 2025, the value is 14.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 2.00 Cr..
  • For Profit before tax, as of Jun 2025, the value is 89.00 Cr.. The value appears to be declining and may need further review. It has decreased from 107.00 Cr. (Mar 2025) to 89.00 Cr., marking a decrease of 18.00 Cr..
  • For Tax %, as of Jun 2025, the value is 22.00%. The value appears to be improving (decreasing) as expected. It has decreased from 30.00% (Mar 2025) to 22.00%, marking a decrease of 8.00%.
  • For Net Profit, as of Jun 2025, the value is 69.00 Cr.. The value appears to be declining and may need further review. It has decreased from 75.00 Cr. (Mar 2025) to 69.00 Cr., marking a decrease of 6.00 Cr..
  • For EPS in Rs, as of Jun 2025, the value is 2.01. The value appears to be declining and may need further review. It has decreased from 2.17 (Mar 2025) to 2.01, marking a decrease of 0.16.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:40 pm

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Sales 1,8171,5731,5632,0742,3352,3732,526
Expenses 1,5471,3471,4131,8832,1102,0242,204
Operating Profit 270226150191225349322
OPM % 15%14%10%9%10%15%13%
Other Income 585979658173115
Interest 7151214182227
Depreciation 30525557575960
Profit before tax 290218162186232341350
Tax % 30%26%26%26%26%23%24%
Net Profit 202161121137172264267
EPS in Rs 5.794.763.593.975.007.577.73
Dividend Payout % 59%79%106%75%66%50%56%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-20.30%-24.84%13.22%25.55%53.49%1.14%
Change in YoY Net Profit Growth (%)0.00%-4.55%38.07%12.32%27.94%-52.35%

Balmer Lawrie Investment Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2019-2020 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:%
5 Years:10%
3 Years:7%
TTM:7%
Compounded Profit Growth
10 Years:%
5 Years:10%
3 Years:26%
TTM:2%
Stock Price CAGR
10 Years:13%
5 Years:18%
3 Years:29%
1 Year:-3%
Return on Equity
10 Years:%
5 Years:11%
3 Years:12%
Last Year:13%

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:45 pm

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital 22222222222222
Reserves 1,0521,0811,0761,0941,1171,1991,354
Borrowings 81122125122121113106
Other Liabilities 1,2661,2561,3041,3401,5401,6911,720
Total Liabilities 2,4202,4822,5272,5782,8013,0253,201
Fixed Assets 568770767767760751737
CWIP 117243211285267
Investments 325375386436518565632
Other Assets 1,4101,3131,3411,3641,4951,6571,766
Total Assets 2,4202,4822,5272,5782,8013,0253,201

Below is a detailed analysis of the balance sheet data for Balmer Lawrie Investment Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Mar 2025, the value is 22.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 22.00 Cr..
  • For Reserves, as of Mar 2025, the value is 1,354.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,199.00 Cr. (Mar 2024) to 1,354.00 Cr., marking an increase of 155.00 Cr..
  • For Borrowings, as of Mar 2025, the value is 106.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 113.00 Cr. (Mar 2024) to 106.00 Cr., marking a decrease of 7.00 Cr..
  • For Other Liabilities, as of Mar 2025, the value is 1,720.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,691.00 Cr. (Mar 2024) to 1,720.00 Cr., marking an increase of 29.00 Cr..
  • For Total Liabilities, as of Mar 2025, the value is 3,201.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,025.00 Cr. (Mar 2024) to 3,201.00 Cr., marking an increase of 176.00 Cr..
  • For Fixed Assets, as of Mar 2025, the value is 737.00 Cr.. The value appears to be declining and may need further review. It has decreased from 751.00 Cr. (Mar 2024) to 737.00 Cr., marking a decrease of 14.00 Cr..
  • For CWIP, as of Mar 2025, the value is 67.00 Cr.. The value appears strong and on an upward trend. It has increased from 52.00 Cr. (Mar 2024) to 67.00 Cr., marking an increase of 15.00 Cr..
  • For Investments, as of Mar 2025, the value is 632.00 Cr.. The value appears strong and on an upward trend. It has increased from 565.00 Cr. (Mar 2024) to 632.00 Cr., marking an increase of 67.00 Cr..
  • For Other Assets, as of Mar 2025, the value is 1,766.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,657.00 Cr. (Mar 2024) to 1,766.00 Cr., marking an increase of 109.00 Cr..
  • For Total Assets, as of Mar 2025, the value is 3,201.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,025.00 Cr. (Mar 2024) to 3,201.00 Cr., marking an increase of 176.00 Cr..

Notably, the Reserves (1,354.00 Cr.) exceed the Borrowings (106.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +17718724723206269164
Cash from Investing Activity +-137-60-80137-48-1059
Cash from Financing Activity +-61-159-153-148-145-172-183
Net Cash Flow-21-32141213-9-10

Free Cash Flow

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow189.00104.0025.0069.00104.00236.00216.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days56636755566669
Inventory Days47585851474742
Days Payable0889968697566
Cash Conversion Cycle102332738353746
Working Capital Days42513251414261
ROCE %13%9%11%13%18%17%

Financial Efficiency Indicators Chart

No valid data available for the Shareholding

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.0010.0010.0010.0010.00
Basic EPS (Rs.) 0.7775.6849.9839.8835.92
Diluted EPS (Rs.) 0.7775.6849.9839.8835.92
Cash EPS (Rs.) 11.82119.3175.8666.8864.41
Book Value[Excl.RevalReserv]/Share (Rs.) 61.98549.97500.91788.73777.64
Book Value[Incl.RevalReserv]/Share (Rs.) 61.98549.97500.91788.73777.64
Revenue From Operations / Share (Rs.) 113.811057.871048.95928.38692.07
PBDIT / Share (Rs.) 16.78164.10110.6194.8688.56
PBIT / Share (Rs.) 14.06137.4485.0269.7363.78
PBT / Share (Rs.) 12.87127.5176.9463.6058.41
Net Profit / Share (Rs.) 9.1092.6550.2841.7439.62
NP After MI And SOA / Share (Rs.) 7.7375.6849.9839.8835.92
PBDIT Margin (%) 14.7415.5110.5410.2112.79
PBIT Margin (%) 12.3512.998.107.519.21
PBT Margin (%) 11.3012.057.336.858.43
Net Profit Margin (%) 7.998.754.794.495.72
NP After MI And SOA Margin (%) 6.797.154.764.295.18
Return on Networth / Equity (%) 12.4713.769.977.927.26
Return on Capital Employeed (%) 12.4713.218.767.567.09
Return On Assets (%) 5.365.553.963.433.15
Long Term Debt / Equity (X) 0.050.050.070.070.08
Total Debt / Equity (X) 0.050.060.080.080.08
Asset Turnover Ratio (%) 0.810.800.860.050.06
Current Ratio (X) 2.492.292.292.542.51
Quick Ratio (X) 2.222.021.982.162.20
Inventory Turnover Ratio (X) 8.307.487.880.000.00
Dividend Payout Ratio (NP) (%) 0.0043.6060.0295.29104.40
Dividend Payout Ratio (CP) (%) 0.0032.2439.7058.4561.77
Earning Retention Ratio (%) 0.0056.4039.984.71-4.40
Cash Earning Retention Ratio (%) 0.0067.7660.3041.5538.23
Interest Coverage Ratio (X) 14.0416.5213.6915.4916.50
Interest Coverage Ratio (Post Tax) (X) 8.6210.337.227.828.38
Enterprise Value (Cr.) 1724.291534.201027.011008.401085.04
EV / Net Operating Revenue (X) 0.680.650.440.480.70
EV / EBITDA (X) 4.634.214.184.795.52
MarketCap / Net Operating Revenue (X) 0.590.570.330.390.67
Retention Ratios (%) 0.0056.3939.974.70-4.40
Price / BV (X) 1.091.110.700.730.94
Price / Net Operating Revenue (X) 0.590.570.330.390.67
EarningsYield 0.110.120.140.100.07

After reviewing the key financial ratios for Balmer Lawrie Investment Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 10.00 (Mar 24) to 1.00, marking a decrease of 9.00.
  • For Basic EPS (Rs.), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 5. It has decreased from 75.68 (Mar 24) to 0.77, marking a decrease of 74.91.
  • For Diluted EPS (Rs.), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 5. It has decreased from 75.68 (Mar 24) to 0.77, marking a decrease of 74.91.
  • For Cash EPS (Rs.), as of Mar 25, the value is 11.82. This value is within the healthy range. It has decreased from 119.31 (Mar 24) to 11.82, marking a decrease of 107.49.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.98. It has decreased from 549.97 (Mar 24) to 61.98, marking a decrease of 487.99.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.98. It has decreased from 549.97 (Mar 24) to 61.98, marking a decrease of 487.99.
  • For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 113.81. It has decreased from 1,057.87 (Mar 24) to 113.81, marking a decrease of 944.06.
  • For PBDIT / Share (Rs.), as of Mar 25, the value is 16.78. This value is within the healthy range. It has decreased from 164.10 (Mar 24) to 16.78, marking a decrease of 147.32.
  • For PBIT / Share (Rs.), as of Mar 25, the value is 14.06. This value is within the healthy range. It has decreased from 137.44 (Mar 24) to 14.06, marking a decrease of 123.38.
  • For PBT / Share (Rs.), as of Mar 25, the value is 12.87. This value is within the healthy range. It has decreased from 127.51 (Mar 24) to 12.87, marking a decrease of 114.64.
  • For Net Profit / Share (Rs.), as of Mar 25, the value is 9.10. This value is within the healthy range. It has decreased from 92.65 (Mar 24) to 9.10, marking a decrease of 83.55.
  • For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.73. This value is within the healthy range. It has decreased from 75.68 (Mar 24) to 7.73, marking a decrease of 67.95.
  • For PBDIT Margin (%), as of Mar 25, the value is 14.74. This value is within the healthy range. It has decreased from 15.51 (Mar 24) to 14.74, marking a decrease of 0.77.
  • For PBIT Margin (%), as of Mar 25, the value is 12.35. This value is within the healthy range. It has decreased from 12.99 (Mar 24) to 12.35, marking a decrease of 0.64.
  • For PBT Margin (%), as of Mar 25, the value is 11.30. This value is within the healthy range. It has decreased from 12.05 (Mar 24) to 11.30, marking a decrease of 0.75.
  • For Net Profit Margin (%), as of Mar 25, the value is 7.99. This value is within the healthy range. It has decreased from 8.75 (Mar 24) to 7.99, marking a decrease of 0.76.
  • For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.79. This value is below the healthy minimum of 8. It has decreased from 7.15 (Mar 24) to 6.79, marking a decrease of 0.36.
  • For Return on Networth / Equity (%), as of Mar 25, the value is 12.47. This value is below the healthy minimum of 15. It has decreased from 13.76 (Mar 24) to 12.47, marking a decrease of 1.29.
  • For Return on Capital Employeed (%), as of Mar 25, the value is 12.47. This value is within the healthy range. It has decreased from 13.21 (Mar 24) to 12.47, marking a decrease of 0.74.
  • For Return On Assets (%), as of Mar 25, the value is 5.36. This value is within the healthy range. It has decreased from 5.55 (Mar 24) to 5.36, marking a decrease of 0.19.
  • For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.05.
  • For Total Debt / Equity (X), as of Mar 25, the value is 0.05. This value is within the healthy range. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.
  • For Asset Turnover Ratio (%), as of Mar 25, the value is 0.81. It has increased from 0.80 (Mar 24) to 0.81, marking an increase of 0.01.
  • For Current Ratio (X), as of Mar 25, the value is 2.49. This value is within the healthy range. It has increased from 2.29 (Mar 24) to 2.49, marking an increase of 0.20.
  • For Quick Ratio (X), as of Mar 25, the value is 2.22. This value exceeds the healthy maximum of 2. It has increased from 2.02 (Mar 24) to 2.22, marking an increase of 0.20.
  • For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.30. This value exceeds the healthy maximum of 8. It has increased from 7.48 (Mar 24) to 8.30, marking an increase of 0.82.
  • For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 43.60 (Mar 24) to 0.00, marking a decrease of 43.60.
  • For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 32.24 (Mar 24) to 0.00, marking a decrease of 32.24.
  • For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 56.40 (Mar 24) to 0.00, marking a decrease of 56.40.
  • For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 67.76 (Mar 24) to 0.00, marking a decrease of 67.76.
  • For Interest Coverage Ratio (X), as of Mar 25, the value is 14.04. This value is within the healthy range. It has decreased from 16.52 (Mar 24) to 14.04, marking a decrease of 2.48.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 8.62. This value is within the healthy range. It has decreased from 10.33 (Mar 24) to 8.62, marking a decrease of 1.71.
  • For Enterprise Value (Cr.), as of Mar 25, the value is 1,724.29. It has increased from 1,534.20 (Mar 24) to 1,724.29, marking an increase of 190.09.
  • For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.68, marking an increase of 0.03.
  • For EV / EBITDA (X), as of Mar 25, the value is 4.63. This value is below the healthy minimum of 5. It has increased from 4.21 (Mar 24) to 4.63, marking an increase of 0.42.
  • For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 24) to 0.59, marking an increase of 0.02.
  • For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 56.39 (Mar 24) to 0.00, marking a decrease of 56.39.
  • For Price / BV (X), as of Mar 25, the value is 1.09. This value is within the healthy range. It has decreased from 1.11 (Mar 24) to 1.09, marking a decrease of 0.02.
  • For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 24) to 0.59, marking an increase of 0.02.
  • For EarningsYield, as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. It has decreased from 0.12 (Mar 24) to 0.11, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Balmer Lawrie Investment Ltd as of August 22, 2025 is: 79.52

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of August 22, 2025, Balmer Lawrie Investment Ltd is Overvalued by 13.00% compared to the current share price 91.40

Intrinsic Value of Balmer Lawrie Investment Ltd as of August 22, 2025 is: 92.70

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of August 22, 2025, Balmer Lawrie Investment Ltd is Undervalued by 1.42% compared to the current share price 91.40

Last 5 Year EPS CAGR: 16.58%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The company has higher reserves (1,139.00 cr) compared to borrowings (112.86 cr), indicating strong financial stability.
  2. The company has shown consistent growth in sales (1.57 cr) and profit (254.14 cr) over the years.
  1. The stock has a low average ROCE of 11.57%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 45.71, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 45.43, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Balmer Lawrie Investment Ltd:
    1. Net Profit Margin: 7.99%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 12.47% (Industry Average ROCE: 15.8%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 12.47% (Industry Average ROE: 8.89%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 8.62
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 2.22
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 11.6 (Industry average Stock P/E: 101.91)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.05
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Balmer Lawrie Investments Ltd. is a Public Limited Listed company incorporated on 20/09/2001 and has its registered office in the State of West Bengal, India. Company's Corporate Identification Number(CIN) is L65999WB2001GOI093759 and registration number is 093759. Currently company belongs to the Industry of Non-Banking Financial Company (NBFC). Company's Total Operating Revenue is Rs. 101.11 Cr. and Equity Capital is Rs. 22.20 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Non-Banking Financial Company (NBFC)21, Netaji Subhas Road, Kolkata West Bengal 700001lahoti.a@balmerlawrie.com
http://www.blinv.com
Management
NamePosition Held
Mr. Saurav DuttaNon Executive Chairman
Mr. Arvind Nath JhaGovernment Nominee Director
Mr. Samir Kumar MohantyGovernment Nominee Director

FAQ

What is the intrinsic value of Balmer Lawrie Investment Ltd?

Balmer Lawrie Investment Ltd's intrinsic value (as of 22 August 2025) is ₹79.52 which is 13.00% lower the current market price of ₹91.40, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹2,029 Cr. market cap, FY2025-2026 high/low of 100/60.0, reserves of ₹1,354 Cr, and liabilities of ₹3,201 Cr.

What is the Market Cap of Balmer Lawrie Investment Ltd?

The Market Cap of Balmer Lawrie Investment Ltd is 2,029 Cr..

What is the current Stock Price of Balmer Lawrie Investment Ltd as on 22 August 2025?

The current stock price of Balmer Lawrie Investment Ltd as on 22 August 2025 is 91.4.

What is the High / Low of Balmer Lawrie Investment Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Balmer Lawrie Investment Ltd stocks is 100/60.0.

What is the Stock P/E of Balmer Lawrie Investment Ltd?

The Stock P/E of Balmer Lawrie Investment Ltd is 11.6.

What is the Book Value of Balmer Lawrie Investment Ltd?

The Book Value of Balmer Lawrie Investment Ltd is 62.0.

What is the Dividend Yield of Balmer Lawrie Investment Ltd?

The Dividend Yield of Balmer Lawrie Investment Ltd is 4.70 %.

What is the ROCE of Balmer Lawrie Investment Ltd?

The ROCE of Balmer Lawrie Investment Ltd is 17.3 %.

What is the ROE of Balmer Lawrie Investment Ltd?

The ROE of Balmer Lawrie Investment Ltd is 13.2 %.

What is the Face Value of Balmer Lawrie Investment Ltd?

The Face Value of Balmer Lawrie Investment Ltd is 1.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Balmer Lawrie Investment Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE